Maintenance Inhalers for Asthma and COPD in Spain.

BACKGROUND: This study aimed to describe the use of pressurized metered-dose inhalers (pMDIs) and dry powder inhalers (DPIs) in Spanish subjects in terms of sociodemographic, clinical, and functional characteristics in subjects with asthma or COPD on maintenance treatment with inhaled therapy. METHO...

Full description

Bibliographic Details
Published in:Respiratory Care Vol. 69; no. 12; pp. 1534 - 1543
Main Authors: Muñoz, Xavier, Giner, Jordi, Sicras, Antoni, Lo Re, Daniele
Format: research tables/charts Journal Article
Published: Mary Ann Liebert, Inc. Dec2024
Online Access:View this record in EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=181078488&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 181078488
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        00201324
        4GG
      jtl: Respiratory Care
      issn: 00201324
      maglogo: N
    pubinfo:
      dt: Dec2024
      vid: 69
      iid: 12
      pid: 1365
      pub: Mary Ann Liebert, Inc.
      place: New Rochelle, New York
    artinfo:
      ui:
        181078488
        181078488
        181078488
        10.4187/respcare.11643
        181078488
      ppf: 1534
      ppct: 9
      formats:
        fmt:
          @attributes:
            type: P
      tig:
        atl: Maintenance Inhalers for Asthma and COPD in Spain.
      aug:
        au:
          Muñoz, Xavier
          Giner, Jordi
          Sicras, Antoni
          Lo Re, Daniele
        affil: Vall'd Hebrón Hospital, Department of Pneumology, Barcelona, Spain
      sug:
        subj:
          Pulmonary Disease, Chronic Obstructive Drug Therapy
          Asthma Drug Therapy
          Nebulizers and Vaporizers Utilization
          Powders Administration and Dosage
          Patient Preference
          Treatment Outcomes
          Human
          Funding Source
          Spain
          Male
          Female
          Adolescence
          Adult
          Middle Age
          Aged
          Aged, 80 and Over
          Retrospective Design
          Record Review
          Descriptive Statistics
          Multicenter Studies
          Nonexperimental Studies
          Univariate Statistics
          Nonparametric Statistics
          Confidence Intervals
          Bivariate Statistics
          Analysis of Variance
          Chi Square Test
          Age Factors
          Equipment Design
          Drug Therapy, Combination
          Adolescent: 13-18 years
          Adult: 19-44 years
          Middle Aged: 45-64 years
          Aged: 65+ years
          Aged, 80 & over
          Male
          Female
      ab: BACKGROUND: This study aimed to describe the use of pressurized metered-dose inhalers (pMDIs) and dry powder inhalers (DPIs) in Spanish subjects in terms of sociodemographic, clinical, and functional characteristics in subjects with asthma or COPD on maintenance treatment with inhaled therapy. METHODS: This was a retrospective, descriptive, national, multi-center, and observational study using a database with 1.8 million patients from hospitals and primary care centers as a secondary information source. RESULTS: The sample included 24,102 subjects with asthma on maintenance therapy (26.0% with pMDI, 55% with DPI, and 19.0% with a combination of DPI + pMDI inhalers) and 12,858 subjects with COPD on maintenance therapy (26% with pMDI; 39% with DPI; and 35% with a combination of pMDI + DPI inhalers, mostly extemporary triple therapy). In proportion, subjects ≥ 75 y old used more pMDI than DPI, while younger subjects (40-64 y old) used more DPI. An inhalation chamber was prescribed in 51.0% of subjects with asthma and 47.2% of subjects with COPD treated with pMDI. The use of an inhalation chamber increases with the degree of air-flow limitation by disease and age. In subjects with comorbidities, pMDI inhaler use increased in those ≥ 75 y old for subjects with asthma and subjects with COPD. Switching from pMDI to DPI and vice versa was relatively common: 25% of subjects with asthma and 21.6% of subjects with COPD treated with pMDI had switched from DPI in the previous year. On the contrary, 14.1% and 11.4% of subjects with asthma and subjects with COPD, respectively, treated with DPI had switched from pMDI the last year. CONCLUSIONS: The use of pMDI or DPI can vary according to age, both in asthma and COPD. Switching from pMDI to DPI and vice versa is relatively common. Despite the availability of dual- and triple-therapy inhalers on the market, a considerable number of subjects were treated with multiple devices.
      pubtype: Academic Journal
      doctype:
        research
        tables/charts
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N